TMCnet News
Stimatix GI Ltd. Announces the Appointment of Eric G. Weiss, M.D., as Medical AdvisorMISGAV BUSINESS PARK, Israel --(Business Wire)-- Stimatix GI Ltd., a medical device company focused on continence solutions, today announced that it has appointed Eric G. Weiss, M.D., as Medical Advisor. Eric G. Weiss, MD, FASCRS, FACS, FACG is the Vice Chairman of the Department of Colorectal Surgery at Cleveland Clinic Florida. In addition he serves as the DIO and Chairman of Graduate Medical, as well as the Residency Program Director of the Colorectal Surgery Residency Training program, one of the largest training programs in the country. He currently serves as the Chairman of the Residency Review Committee for Colon and Rectal Surgery. He is also the Director of Surgical Endoscopy. Dr. Weiss holds academic appointments as Clinical Professor of Surgery at Florida International University in Miami, Florida. In addition he is an Assistant Professor of Surgery at The Cleveland Clinic Foundation Health Sciences Center of the Ohio State University and a Clinical Assistant Professor of Surgery at the University of South Florida, Tampa, Florida. He has published more than 200 manuscripts, more than 40 textbook chapters and over 400 lectures throughout the United States and the world. "Dr. Weiss's tremendous experience in colon and rectal surgery with clinical interests in fecal incontinence, colorectal cancer, inflammatory bowel disease and laparoscopic surgery will be of incredible value to Stimatix GI," remarked David Hanuka, CEO of Stimatix GI Ltd. "I am delighted and honored to have Dr. Eric G. Weiss join our Medical Advisory Board." Dr. Weiss stated that "in the course of many operations that are performed in colorectal surgery, patients either temporarily or permanently require a stoma. I am extremely excited to be working with Stimatix GI, a leader in changing the lives of ostomates with new innovations to improve the quality of life of these patients." About Stimatix GI Stimatix GI, founded in June 2009, is a portfolio company of The Trendlines Group's Misgav Venture Accelerator. Stimatix GI develops innovative continence management devices for people with stoma intended to improve quality of life.
|
